Profile
Guy Ely is Vice President of Clinical and Medical Affairs of Biomira, Inc. Previously, he was Vice President of Clinical and Medical Affairs for Biomira from 2001 to 2006.
He was Vice President of Clinical and Medical Affairs for Lorus Therapeutics from 1997 to 2001.
From 1995 to 199, Dr. Ely was Associate Medical Director of SmithKline Beecham Canada, Inc. He was Vice President of Clinical and Medical Affairs for Biochem Therapeutics, Inc. from 1991 to 1995 and Director of Clinical Research for Abbott Laboratories Canada, Inc. from 1989 to 1991.
He was Medical Director of Asta Medica from 1988 to 1989, Manager of Clinical Investigation and Medical Advisor for Ciba-Geigy Canada, Inc. from 1986 to 1988.
Former positions of Guy Ely
| Companies | Position | End |
|---|---|---|
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Chief Tech/Sci/R&D Officer | 10/12/2007 |
Chemokine Therapeutics Corp.
 Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 15/11/2007 |
| APTOSE BIOSCIENCES INC. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| APTOSE BIOSCIENCES INC. | Health Technology |
| Private companies | 2 |
|---|---|
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Health Services |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Guy Ely